Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Prostatic Neoplasms: HELP
Kim Nguyen Chi
Based on 84 articles published since 2009
(Why 84 articles?)
||||
Expertise Level
The expertise of Kim Nguyen Chi ranks in the
  • Top 0.04%
  • ... of 131,908 published authors worldwide on Prostatic Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 84 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Chi, Kim N   ·   Chi, Kim   ·   Chi, Kim Nguyen   ·   Chi, K N
Work Locations
Details
Most likely:    University of British Columbia      
2019
  • From BC Cancer and Vancouver Prostate Centre, Vancouver, Canada (K.N.C.) · Huntsman Cancer Institute, University of Utah, Salt Lake City (N.A.) · Skåne University Hospital, Lund University, Malmö, Sweden (A.B.) · Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea (B.H.C.) · Liga Norte Riograndense Contra o Câncer, Natal, Brazil (A.J.P.S.G.) · Urology of Virginia, Eastern Virginia Medical School, Norfolk (R.G.) · Hospital Universitario de Jerez de la Frontera, Cadiz, Spain (A.J.S.) · University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany (A.S.M.) · Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey (M.O.) · Kindai University Hospital Faculty of Medicine, Osaka, Japan (H.U.) · Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.) · Janssen Research and Development, Beerse, Belgium (K.D.) · Janssen Research and Development, San Diego (V.N., J.L., K.Z.), and Janssen Research and Development, Los Angeles (M.K.Y., J.S.L.) - both in California · Janssen Research and Development, Raritan, NJ (S. Cheng, S.M.) · and Guy's, King's, and St. Thomas' Hospitals and the Sarah Cannon Research Institute, London (S. Chowdhury). · Pubmed 31150574
2018
  • Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Oncology, McMaster University, Hamilton, ON, Canada. · Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB, Canada. · Kinghorn Cancer Center, St Vincents Hospital, Sydney, NSW, Australia. · Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 29250742
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA. · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA. · Department of Radiation Oncology, UCSF, San Francisco, CA, USA. · Cancer Biology Division, Department of Radiation Oncology, Washington University in St. Louis, MO USA; Institute for Informatics (I(2)), Washington University in St. Louis, MO. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Oregon Health and Science University, Portland, OR, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA; VA Greater Los Angeles Healthcare System, Department of Medicine, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA. · Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. · Department of Biophysics and Biochemistry, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA. · Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA; Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. · Illumina, Inc., San Diego, CA, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada. · Department of Pathology, Duke University, Durham, NC, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address: · Pubmed 30033370
  • Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, University Medical Center, University of Mainz, Mainz, Germany. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Dept. of Urologic Sciences, University of British Columbia, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 6th Floor, Vancouver, BC, V5Z1M9, Canada. · Pubmed 29488095
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia. · School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. · Breast Cancer Genetics Group, Centre for Personalised Cancer Medicine, School of Medicine, The University of Adelaide, SA 5005, Australia. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. · Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. · Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia. · GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada. · Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. · Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Australian Prostate Cancer Research Centre Queensland, Translational Research Institute, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Australia. · School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan. · Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 28011622
  • Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; Department of Urology, University Hospital, Tübingen, Germany. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada; Department of Medicine, Monash University, Melbourne, Victoria, Australia. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; British Columbia Cancer Agency, British Columbia, Vancouver, Canada. Electronic address: · Pubmed 27436429
2016
  • Department of Urology, University Hospital, Tuebingen, Germany. · Vancouver Prostate Centre, Vancouver, BC, Canada. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 27430478
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Department of Life, Health, and Chemical Sciences, The Open University, Milton Keynes, UK. · Molecular Pathology Unit, Institute of Pathology University Hospital Basel, Switzerland. · Oncology, FHMS, School of Biosciences and Medicine, University of Surrey, UK. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Karolinska Institutet, Institute of Environmental Medicine, Unit of Biostatistics, Stockholm, Sweden. · Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Genetics Unit, Integrative Oncology, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · Cancer Center ZeTuP AG St.Gallen, St.Gallen, Switzerland. · Integrated DNA Technologies, Coralville, IA, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. Electronic address: · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. Electronic address: · Pubmed 26809501
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2015
  • The Vancouver Prostate Centre and Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · The Vancouver Prostate Centre and Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25151015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
  • Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada. · Department of Medicine, Division of Medical Oncology, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 25428917
2014
  • Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Department of Biology, Kwantlen Polytechnic University, Surrey, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24416373
2012
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 22553344
2019
  • From Monash University (I.D.D., M.F., D.W.P.), Eastern Health (I.D.D.), Australian Urology Associates (M.F.), Monash Health (D.W.P.), and the Peter MacCallum Cancer Centre and the University of Melbourne (S.K.S., S.G.W.), Melbourne, VIC, the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (A.J.M., M.R.S., X.C., W.E.H., E.T., S.Y., A.Y.Z.), the Chris O'Brien Lifehouse (M.R.S., L.G.H., A.Y.Z.), the University of Sydney (L.G.H., G.M.), Royal Prince Alfred Hospital (L.G.H.), Kinghorn Cancer Centre, St. Vincent's Hospital, and Garvan Institute of Medical Research (A.M.J.), Macquarie University (A.Y.Z.), and Western Sydney University (R.R.Z.), Sydney, Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW (M.R.S.), Port Macquarie Base Hospital and Mid North Coast Cancer Institute Port Macquarie, Port Macquarie, NSW (S.B.), Sydney Adventist Hospital, Wahroonga, NSW (G.M.), the ANZUP Cancer Trials Group, Camperdown, NSW (M.M.), the Adelaide Cancer Centre and the University of Adelaide (F.P.) and the Royal Adelaide Hospital (T.H.T.), Adelaide, SA, and Orange Health Service, Central West Cancer Care Centre, Orange, NSW (R.R.Z.) - all in Australia · BC Cancer and the University of British Columbia, Vancouver (K.N.C.), the Cross Cancer Institute and the University of Alberta, Edmonton (S.A.N.), Canadian Cancer Trials Group, Queen's University (W.P., F.V.-B.), and the Kingston Health Sciences Center (F.V.-B.), Kingston, ON, and the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.N.R.) - all in Canada · Guy's and St. Thomas' NHS Foundation Trust Biomedical Research Centre, Cancer Research UK and King's College London, and Sarah Cannon Research UK, London (S.C.), and the Royal Cornwall Hospital, Truro (A. Thomson) - all in the United Kingdom · Auckland City Hospital, Auckland (N.J.L.), and the Waikato District Health Board, Hamilton (A. Tan) - both in New Zealand · Cancer Trials Ireland (J.M., R.M.), Mater Misericordiae University Hospital (J.M.), and St. Vincent's University Hospital and University College Dublin (R.M.D.) - all in Dublin · and Dana-Farber Cancer Institute and Harvard Medical School (C.J.S.) - both in Boston. · Pubmed 31157964
2018
  • Department of Mechanical Engineering, University of British Columbia, Canada. · Pubmed 29762619
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • Department of Mechanical Engineering, University of British Columbia, 2054-6250 Applied Science Lane, Vancouver, BC V6T 1Z4, Canada. · Pubmed 25876237
2013
  • The Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC V6H 3Z6, Canada. · Pubmed 23574937
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23492367
Probable:    British Columbia Cancer Agency      
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2660 Oak Street, Vancouver, British Columbia, Canada V6H 3Z6. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2660 Oak Street, Vancouver, British Columbia, Canada V6H 3Z6. Electronic address: · Pubmed 28958406
  • Clinical Trials Unit, BC Cancer-Vancouver Centre, Vancouver, BC, Canada. Electronic address: · Oxford University Hospitals NHS Foundation Trust, Oxford, UK. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Istituto Nazionale Tumori IRCCS-Fondazione G Pascale, Naples, Italy. · Urologikum Hamburg, Hamburg, Germany. · National Cancer Center Hospital East, Chiba, Japan. · Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. · Seoul National University Hospital, Seoul, South Korea. · Americas Medical City, Rio de Janeiro, Brazil. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Buckinghamshire, UK. · Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 29326030
  • Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Oncology, McMaster University, Hamilton, ON, Canada. · Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB, Canada. · Kinghorn Cancer Center, St Vincents Hospital, Sydney, NSW, Australia. · Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 29250742
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA. · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA. · Department of Radiation Oncology, UCSF, San Francisco, CA, USA. · Cancer Biology Division, Department of Radiation Oncology, Washington University in St. Louis, MO USA; Institute for Informatics (I(2)), Washington University in St. Louis, MO. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Oregon Health and Science University, Portland, OR, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA; VA Greater Los Angeles Healthcare System, Department of Medicine, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA. · Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. · Department of Biophysics and Biochemistry, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA. · Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA; Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. · Illumina, Inc., San Diego, CA, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada. · Department of Pathology, Duke University, Durham, NC, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address: · Pubmed 30033370
  • Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, University Medical Center, University of Mainz, Mainz, Germany. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Dept. of Urologic Sciences, University of British Columbia, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 6th Floor, Vancouver, BC, V5Z1M9, Canada. · Pubmed 29488095
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.) · Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.) · National Cancer Center Hospital East, Chiba, Japan (N.M.) · 12 de Octubre University Hospital, Madrid (A.R.-A.) · P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.) · Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.) · Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.) · Studienpraxis Urologie, Nürtingen, Germany (S.F.) · Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.) · Janssen Global Services, Raritan, NJ (M.B.T.) · and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia. · School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. · Breast Cancer Genetics Group, Centre for Personalised Cancer Medicine, School of Medicine, The University of Adelaide, SA 5005, Australia. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. · Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. · Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia. · GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada. · Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. · Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Australian Prostate Cancer Research Centre Queensland, Translational Research Institute, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Australia. · School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan. · Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 28011622
  • Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; Department of Urology, University Hospital, Tübingen, Germany. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada; Department of Medicine, Monash University, Melbourne, Victoria, Australia. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; British Columbia Cancer Agency, British Columbia, Vancouver, Canada. Electronic address: · Pubmed 27436429
  • Institut Gustave Roussy, Villejuif, France · BC Cancer Agency, Vancouver, BC, Canada · Pubmed 29083131
2016
  • Department of Urology, University Hospital, Tuebingen, Germany. · Vancouver Prostate Centre, Vancouver, BC, Canada. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 27430478
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Center, Vancouver, British Columbia, Canada. · Pubmed 27345496
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Tufts University, Boston, MA, USA. · Cross Cancer Institute, Edmonton, AB, Canada. · Medicine Hat Cancer Centre, Medicine Hat, AB, Canada. · London Regional Cancer Centre, London, ON, Canada. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 27565809
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Division of Biostatistics, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Exelixis, Inc, South San Francisco, CA, USA. · Exelixis, Inc, South San Francisco, CA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 26762579
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Pubmed 26813233
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Department of Life, Health, and Chemical Sciences, The Open University, Milton Keynes, UK. · Molecular Pathology Unit, Institute of Pathology University Hospital Basel, Switzerland. · Oncology, FHMS, School of Biosciences and Medicine, University of Surrey, UK. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Karolinska Institutet, Institute of Environmental Medicine, Unit of Biostatistics, Stockholm, Sweden. · Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Genetics Unit, Integrative Oncology, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · Cancer Center ZeTuP AG St.Gallen, St.Gallen, Switzerland. · Integrated DNA Technologies, Coralville, IA, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. Electronic address: · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. Electronic address: · Pubmed 26809501
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2015
  • Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada. · The Vancouver Prostate Centre, 2775 Laurel Street, 6th Floor, Vancouver, BC V5Z 1M9, Canada. · Pubmed 25512207
  • BC Cancer Agency, Vancouver, BC, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Titusville, NJ, USA. · Pubmed 26096139
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Princess Margaret Hospital, Phase II Consortium, Toronto, ON. · Department of Oncology, Queen's University, Kingston, ON. · BC Cancer Agency, Vancouver, BC. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD. · BC Cancer Agency, Vancouver, BC. Electronic address: · Pubmed 24993934
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
  • 1] University of Washington, Seattle, WA, USA [2] Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Sidney Kimmel Cancer Center/Johns Hopkins University, Baltimore, MA, USA. · City of Hope Cancer Center, Duarte, CA, USA. · Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA. · Huntsman Cancer Institute/University of Utah, Salt Lake City, UT, USA. · Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Pubmed 25600186
  • Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada. · Department of Medicine, Division of Medical Oncology, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 25428917
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 25018038
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 24508071
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address: · Pubmed 25864159
2014
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Department of Pathology and Laboratory Medicine and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 24787970
  • Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Department of Biology, Kwantlen Polytechnic University, Surrey, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24416373
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
  • British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 23064959
2012
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 22553344
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Pubmed 21765178
2011
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 22329189
2010
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 20733135
2009
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
2014
  • British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC, Canada. · Pubmed 24671507
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 25175831
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Pubmed 24519926
  • Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada. · Pubmed 24443367
2013
  • BC Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 23660300
  • BC Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6. · Pubmed 23337761
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Pubmed 23585511
2012
  • BC Cancer Agency - Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6. · Pubmed 21785998
2010
  • Division of Medical Oncology, BC Cancer Agency - Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 20152524
  • Department of Medical Oncology, Vancouver Centre, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 19633045
Probable:    Miscellaneous institutions in Vancouver      
2016
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Center, Vancouver, British Columbia, Canada. · Pubmed 27345496
2012
  • Bristish Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, V5Z 4E6, Canada. · Pubmed 23130925
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 84 total) written by Kim Nguyen Chi about Prostatic Neoplasms:

  • Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer. 2019
  • Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. 2019
  • Clinical utility of emerging liquid biomarkers in advanced prostate cancer. 2018
  • Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. 2018
  • A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer. 2018
  • Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer. 2018
  • Isolation and genome sequencing of individual circulating tumor cells using hydrogel encapsulation and laser capture microdissection. 2018
  • The impact of time to metastasis on overall survival in patients with prostate cancer. 2018
  • Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer. 2017
  • Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial. 2017
Show List of Full Article Records
Google Searches

Learn more about Kim Nguyen Chi using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of British Columbia
British Columbia Cancer Agency
Miscellaneous institutions in Vancouver
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of British Columbia
2019
  • From BC Cancer and Vancouver Prostate Centre, Vancouver, Canada (K.N.C.) · Huntsman Cancer Institute, University of Utah, Salt Lake City (N.A.) · Skåne University Hospital, Lund University, Malmö, Sweden (A.B.) · Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea (B.H.C.) · Liga Norte Riograndense Contra o Câncer, Natal, Brazil (A.J.P.S.G.) · Urology of Virginia, Eastern Virginia Medical School, Norfolk (R.G.) · Hospital Universitario de Jerez de la Frontera, Cadiz, Spain (A.J.S.) · University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany (A.S.M.) · Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey (M.O.) · Kindai University Hospital Faculty of Medicine, Osaka, Japan (H.U.) · Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.) · Janssen Research and Development, Beerse, Belgium (K.D.) · Janssen Research and Development, San Diego (V.N., J.L., K.Z.), and Janssen Research and Development, Los Angeles (M.K.Y., J.S.L.) - both in California · Janssen Research and Development, Raritan, NJ (S. Cheng, S.M.) · and Guy's, King's, and St. Thomas' Hospitals and the Sarah Cannon Research Institute, London (S. Chowdhury). · Pubmed 31150574
2018
  • Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Oncology, McMaster University, Hamilton, ON, Canada. · Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB, Canada. · Kinghorn Cancer Center, St Vincents Hospital, Sydney, NSW, Australia. · Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 29250742
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA. · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA. · Department of Radiation Oncology, UCSF, San Francisco, CA, USA. · Cancer Biology Division, Department of Radiation Oncology, Washington University in St. Louis, MO USA; Institute for Informatics (I(2)), Washington University in St. Louis, MO. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Oregon Health and Science University, Portland, OR, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA; VA Greater Los Angeles Healthcare System, Department of Medicine, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA. · Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. · Department of Biophysics and Biochemistry, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA. · Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA; Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. · Illumina, Inc., San Diego, CA, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada. · Department of Pathology, Duke University, Durham, NC, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address: · Pubmed 30033370
  • Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, University Medical Center, University of Mainz, Mainz, Germany. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Dept. of Urologic Sciences, University of British Columbia, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 6th Floor, Vancouver, BC, V5Z1M9, Canada. · Pubmed 29488095
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia. · School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. · Breast Cancer Genetics Group, Centre for Personalised Cancer Medicine, School of Medicine, The University of Adelaide, SA 5005, Australia. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. · Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. · Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia. · GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada. · Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. · Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Australian Prostate Cancer Research Centre Queensland, Translational Research Institute, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Australia. · School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan. · Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 28011622
  • Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; Department of Urology, University Hospital, Tübingen, Germany. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada; Department of Medicine, Monash University, Melbourne, Victoria, Australia. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; British Columbia Cancer Agency, British Columbia, Vancouver, Canada. Electronic address: · Pubmed 27436429
2016
  • Department of Urology, University Hospital, Tuebingen, Germany. · Vancouver Prostate Centre, Vancouver, BC, Canada. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 27430478
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Department of Life, Health, and Chemical Sciences, The Open University, Milton Keynes, UK. · Molecular Pathology Unit, Institute of Pathology University Hospital Basel, Switzerland. · Oncology, FHMS, School of Biosciences and Medicine, University of Surrey, UK. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Karolinska Institutet, Institute of Environmental Medicine, Unit of Biostatistics, Stockholm, Sweden. · Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Genetics Unit, Integrative Oncology, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · Cancer Center ZeTuP AG St.Gallen, St.Gallen, Switzerland. · Integrated DNA Technologies, Coralville, IA, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. Electronic address: · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. Electronic address: · Pubmed 26809501
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2015
  • The Vancouver Prostate Centre and Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · The Vancouver Prostate Centre and Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25151015
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
  • Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada. · Department of Medicine, Division of Medical Oncology, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 25428917
2014
  • Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Department of Biology, Kwantlen Polytechnic University, Surrey, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24416373
2012
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 22553344
2019
  • From Monash University (I.D.D., M.F., D.W.P.), Eastern Health (I.D.D.), Australian Urology Associates (M.F.), Monash Health (D.W.P.), and the Peter MacCallum Cancer Centre and the University of Melbourne (S.K.S., S.G.W.), Melbourne, VIC, the National Health and Medical Research Council Clinical Trials Centre, University of Sydney (A.J.M., M.R.S., X.C., W.E.H., E.T., S.Y., A.Y.Z.), the Chris O'Brien Lifehouse (M.R.S., L.G.H., A.Y.Z.), the University of Sydney (L.G.H., G.M.), Royal Prince Alfred Hospital (L.G.H.), Kinghorn Cancer Centre, St. Vincent's Hospital, and Garvan Institute of Medical Research (A.M.J.), Macquarie University (A.Y.Z.), and Western Sydney University (R.R.Z.), Sydney, Concord Cancer Centre, Concord Repatriation General Hospital, Concord, NSW (M.R.S.), Port Macquarie Base Hospital and Mid North Coast Cancer Institute Port Macquarie, Port Macquarie, NSW (S.B.), Sydney Adventist Hospital, Wahroonga, NSW (G.M.), the ANZUP Cancer Trials Group, Camperdown, NSW (M.M.), the Adelaide Cancer Centre and the University of Adelaide (F.P.) and the Royal Adelaide Hospital (T.H.T.), Adelaide, SA, and Orange Health Service, Central West Cancer Care Centre, Orange, NSW (R.R.Z.) - all in Australia · BC Cancer and the University of British Columbia, Vancouver (K.N.C.), the Cross Cancer Institute and the University of Alberta, Edmonton (S.A.N.), Canadian Cancer Trials Group, Queen's University (W.P., F.V.-B.), and the Kingston Health Sciences Center (F.V.-B.), Kingston, ON, and the University of Ottawa and the Ottawa Hospital Research Institute, Ottawa (M.N.R.) - all in Canada · Guy's and St. Thomas' NHS Foundation Trust Biomedical Research Centre, Cancer Research UK and King's College London, and Sarah Cannon Research UK, London (S.C.), and the Royal Cornwall Hospital, Truro (A. Thomson) - all in the United Kingdom · Auckland City Hospital, Auckland (N.J.L.), and the Waikato District Health Board, Hamilton (A. Tan) - both in New Zealand · Cancer Trials Ireland (J.M., R.M.), Mater Misericordiae University Hospital (J.M.), and St. Vincent's University Hospital and University College Dublin (R.M.D.) - all in Dublin · and Dana-Farber Cancer Institute and Harvard Medical School (C.J.S.) - both in Boston. · Pubmed 31157964
2018
  • Department of Mechanical Engineering, University of British Columbia, Canada. · Pubmed 29762619
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
  • Department of Mechanical Engineering, University of British Columbia, 2054-6250 Applied Science Lane, Vancouver, BC V6T 1Z4, Canada. · Pubmed 25876237
2013
  • The Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, BC V6H 3Z6, Canada. · Pubmed 23574937
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 23492367
British Columbia Cancer Agency
2018
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2660 Oak Street, Vancouver, British Columbia, Canada V6H 3Z6. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, 2660 Oak Street, Vancouver, British Columbia, Canada V6H 3Z6. Electronic address: · Pubmed 28958406
  • Clinical Trials Unit, BC Cancer-Vancouver Centre, Vancouver, BC, Canada. Electronic address: · Oxford University Hospitals NHS Foundation Trust, Oxford, UK. · Hospital Universitario 12 de Octubre, Madrid, Spain. · Istituto Nazionale Tumori IRCCS-Fondazione G Pascale, Naples, Italy. · Urologikum Hamburg, Hamburg, Germany. · National Cancer Center Hospital East, Chiba, Japan. · Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. · Seoul National University Hospital, Seoul, South Korea. · Americas Medical City, Rio de Janeiro, Brazil. · Janssen Global Services, Raritan, NJ, USA. · Janssen Research & Development, Horsham, PA, USA. · Janssen Research & Development, Shanghai, China. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Buckinghamshire, UK. · Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 29326030
  • Division of Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. · Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Oncology, McMaster University, Hamilton, ON, Canada. · Division of Medical Oncology, Cancer Care Manitoba, University of Manitoba, Winnipeg, MB, Canada. · Kinghorn Cancer Center, St Vincents Hospital, Sydney, NSW, Australia. · Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. · Division of Medical Oncology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada. · BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 29250742
  • Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, CA, USA. · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. · Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA. · Department of Radiation Oncology, UCSF, San Francisco, CA, USA. · Cancer Biology Division, Department of Radiation Oncology, Washington University in St. Louis, MO USA; Institute for Informatics (I(2)), Washington University in St. Louis, MO. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. · Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA; Department of Pathology, Oregon Health and Science University, Portland, OR, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; British Columbia Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA; VA Greater Los Angeles Healthcare System, Department of Medicine, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, Department of Urology, UCLA, Los Angeles, CA, USA. · Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. · Division of Hematology, Oncology, and Transplant, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. · Department of Biophysics and Biochemistry, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. · Division of Hematology Oncology, Department of Internal Medicine, University of California Davis, Sacramento, CA, USA; Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA. · Comprehensive Cancer Center, University of California Davis, Sacramento, CA, USA; Department of Urologic Surgery, University of California Davis, Sacramento, CA, USA. · Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · UC Sant Cruz Genome Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA. · Illumina, Inc., San Diego, CA, USA. · Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Princess Margaret Cancer Centre/University Health Network, Toronto, ON, Canada. · Department of Pathology, Duke University, Durham, NC, USA. · Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. · Department of Pathology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Ann Arbor, MI, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA; Howard Hughes Medical Institute, University of Michigan Medical School, Ann Arbor, MI, USA; Department of Urology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: · McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO, USA; Department of Internal Medicine, Washington University in St. Louis, St. Louis, MO, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA. Electronic address: · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address: · Pubmed 30033370
  • Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, University Medical Center, University of Mainz, Mainz, Germany. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Dept. of Urologic Sciences, University of British Columbia, Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 6th Floor, Vancouver, BC, V5Z1M9, Canada. · Pubmed 29488095
2017
  • Eastern Health & Monash University, Melbourne, Australia. · Department of Oncology and Haematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland and University of Bern, Switzerland. · Europa Uomo Prostate Patients, Clayhall Ilford, UK. · The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, London, UK. · Knight Cancer Institute, Oregon Health & Science University, Portland, USA. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, Guy's Hospital, London, UK. · Monash University Eastern Health Clinical School, Melbourne, Australia. · Division of Haematology/Oncology, Columbia University Medical Center, New York. · Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA. · Department of Cancer Medicine, Institut Paoli Calmette, Marseille, France. · Fred Hutchinson Cancer Research Center, University of Washington, Seattle. · Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA. · Clinical Oncology Unit, Queen Elizabeth Hospital Birmingham, University of Birmingham, Birmingham, UK. · Department of Clinical Therapeutics, David H. Koch Centre, Alexandra Hospital, University of Athens, Athens, Greece. · Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA. · Clinical Oncology Academic Unit, Royal Marsden NHS Foundation Trust, London, UK. · Clinical Medicine and Urology at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco (UCSF), San Francisco, USA. · Department of Surgery, Centre Hospitalier de Université de Montréal, Montreal, Canada. · Department of Medicine and Urology, Tulane Cancer Center, New Orleans. · Department of Medicine, University of California, San Francisco, USA. · Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy. · Department of Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, USA. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. · Cliniques Universitaires Saint Luc, Brussels, Belgium. · Pubmed 28838209
  • OHSU Knight Cancer Institute, Portland, OR, USA. Electronic address: · Juravinski Cancer Centre, Hamilton, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, Montréal, QC, Canada. · P A Herzen Moscow Cancer Research Institute, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · N N Blokhin Cancer Research Center, Ministry of Healthcare of the Russian Federation, Moscow, Russia. · Centre Leon Berard, Lyon, France. · Institute Paoli-Calmettes, Marseille, France. · Centre François Baclesse, Caen, France. · University of British Columbia, BC Cancer Agency-Vancouver Centre, Vancouver, BC, Canada. · The Clatterbridge Cancer Centre, Bebington, UK. · Trial Architecture Consulting, Washington, DC, USA. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Gustave Roussy, University of Paris Saclay, Villejuif, France. · Pubmed 29033099
  • From Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.) · Janssen Research and Development, Los Angeles (N.T.), Beerse, Belgium (P.D.P.), San Diego, CA (T.K.), and Raritan, NJ (Y.C.P.) · Instituto de Oncologia de Rosário, Rosário, Argentina (L.F.) · National Cancer Center Hospital East, Chiba, Japan (N.M.) · 12 de Octubre University Hospital, Madrid (A.R.-A.) · P.A. Hertsen Moscow Cancer Research Institute, Moscow (B.Y.A.) · Cerrahpaşa Medical Faculty, Istanbul University, Istanbul, Turkey (M.Ö.) · Fudan University Shanghai Cancer Center, Shanghai, China (D.Y.) · Studienpraxis Urologie, Nürtingen, Germany (S.F.) · Oxford University Hospitals Foundation NHS Trust, Oxford, United Kingdom (A.P.) · Janssen Global Services, Raritan, NJ (M.B.T.) · and BC Cancer Agency, Vancouver, Canada (K.N.C.). · Pubmed 28578607
  • Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. Electronic address: · Department of Medicine, Division of Medical Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Trial Architecture Consulting, Washington, DC, USA. · Centre Antoine Lacassagne, Nice, France. · Florida Cancer Specialists, Fort Myers, FL, USA. · Department of Urology, Tübingen, Germany. · Institut Paoli Calmette, Department of Cancer Medicine, Marseille, France. · Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany. · University of Tübingen, Tübingen, Germany. · Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands. · Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, ON, Canada. · Durham Regional Cancer Centre, Oshawa, ON, Canada. · Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. · OncoGenex Pharmaceuticals, Bothell, WA, USA. · Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver Prostate Centre, Vancouver, BC, Canada. · Drug Development Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK. · Pubmed 28283282
  • Drug Development Department, Gustave Roussy, University of Paris Sud, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, Canada. · University Hospital 12 de Octubre, CIBER-ONC, Madrid, Spain. · Institute of Cancer Research, London, UK. · Institut Paoli-Calmettes, Marseille, France. · St. Augustinus Hospital, Antwerp, Belgium. · Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, Brussels, Belgium. · Cedars-Sinai Medical Center, Los Angeles, CA, USA. · Medical Oncology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain. · Novartis Pharma S.A.S, Rueil-Malmaison, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Pvt. Ltd., Hyderabad, India. · Department of Cancer Medicine, Gustave Roussy, University of Paris Sud, France. · Pubmed 28282611
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland. · RSM Durham Regional Cancer Centre, Oshawa, Ontario, Canada. · University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, British Columbia, Canada. Electronic address: · Pubmed 28259476
  • Department of Medicine, University of Washington, Seattle, Washington. · Department of Pathology, University of Washington, Seattle, Washington. · Princess Margaret Cancer Centre, Toronto, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, Canada. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington. · Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. · BC Cancer Agency and University of British Columbia, Vancouver, Canada. · Department of Urology, University of Washington, Seattle, Washington. · Department of Urology, Emory University, Atlanta, Georgia. · Medivation, Inc., San Francisco, California. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Memorial Sloan Kettering Cancer Center, New York, New York. · Geriatric Research, Education and Clinical Center, VA Puget Sound Health Care System, and Department of Medicine, Division of Gerontology & Geriatric Medicine, University of Washington, Seattle, Washington. · Department of Medicine, University of Washington, Seattle, Washington. · Brigham and Women's Hospital, Boston, Massachusetts. · Astellas Pharma, Inc., Northbrook, Illinois. · Pubmed 28151719
  • Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Freemasons Foundation Centre for Men's Health, School of Medicine, The University of Adelaide, South Australia, Australia. · Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, South Australia, Australia. · School of Medicine, University of Adelaide, Adelaide, South Australia, Australia. · Breast Cancer Genetics Group, Centre for Personalised Cancer Medicine, School of Medicine, The University of Adelaide, SA 5005, Australia. · Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. · Cancer Theme, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia. · Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia. · GenomeDx Biosciences Inc., Vancouver, British Columbia, Canada. · Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Mayo Clinic, Rochester, Minnesota. · Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland. · Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania. · Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Australian Prostate Cancer Research Centre Queensland, Translational Research Institute, Princess Alexandra Hospital, Queensland University of Technology, Brisbane, Australia. · School of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. · Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan. · Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan. · Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, The University of Adelaide, South Australia, Australia. · Pubmed 28011622
  • Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; Department of Urology, University Hospital, Tübingen, Germany. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada; Department of Medicine, Monash University, Melbourne, Victoria, Australia. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada. · British Columbia Cancer Agency, British Columbia, Vancouver, Canada. · Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Vancouver Prostate Centre, University of British Columbia, British Columbia, Vancouver, Canada; British Columbia Cancer Agency, British Columbia, Vancouver, Canada. Electronic address: · Pubmed 27436429
  • Institut Gustave Roussy, Villejuif, France · BC Cancer Agency, Vancouver, BC, Canada · Pubmed 29083131
2016
  • Department of Urology, University Hospital, Tuebingen, Germany. · Vancouver Prostate Centre, Vancouver, BC, Canada. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 27430478
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Center, Vancouver, British Columbia, Canada. · Pubmed 27345496
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Tufts University, Boston, MA, USA. · Cross Cancer Institute, Edmonton, AB, Canada. · Medicine Hat Cancer Centre, Medicine Hat, AB, Canada. · London Regional Cancer Centre, London, ON, Canada. · Tom Baker Cancer Centre, Calgary, AB, Canada. · Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Pubmed 27565809
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada · University of Washington, Fred Hutchinson Cancer Research Center, Seattle. · Clinical Development, OncoGenex Pharmaceuticals, Inc., Bothell, USA. · Department of Urologic Sciences, Vancouver Prostate Center, University of British Columbia, Vancouver, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver. · Department of Medical Oncology, Juravinski Cancer Centre, Hamilton, Canada. · Pubmed 27022067
  • Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Division of Biostatistics, Princess Margaret Cancer Center, University Health Network, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel. · Exelixis, Inc, South San Francisco, CA, USA. · Exelixis, Inc, South San Francisco, CA, USA. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. · Pubmed 26762579
  • Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada · Janssen Research & Development, San Diego. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco. · Janssen Research & Development, Menlo Park. · Department of Solid Tumor Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston. · Comprehensive Cancer Centers of Nevada, Las Vegas. · Department of Oncology and Internal Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Groupe Uro-Genitologie, Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Johnson & Johnson Medical China, Shanghai, China. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Tom Baker Cancer Center and University of Calgary, Calgary. · Department of Medical Oncology, Princess Margaret Hospital and University of Toronto, Toronto, Canada. · Drug Development Unit, Division of Cancer Therapeutics/Clinical Studies, The Institute for Cancer Research and Royal Marsden Hospital, Sutton, UK. · Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA. · Pubmed 26685010
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada3School of Clinical Sciences, Monash University, Melbourne, Australia. · Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada2Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 27148695
  • Institut Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: · BC Cancer Agency, Vancouver, BC, Canada. · The Institute of Cancer Research and The Royal Marsden Hospital, Sutton, UK. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Charité-Universitätsmedizin Berlin, Berlin, Germany. · Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, Horsham, PA, USA. · Janssen Scientific Affairs, Horsham, PA, USA. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Global Services, Raritan, NJ, USA. · University of Washington, Seattle, WA, USA. · Pubmed 26965562
  • Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC · William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA · Haojin Zhou, Merck, Beijing, China · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France · Catherine M. Tangen, Southwest Oncology Group Statistical Center · Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia · Daniel P. Petrylak, Yale Cancer Center, New Haven, CT · Maha Hussain, University of Michigan, Ann Arbor, MI · Nicholas J. Vogelzang, US Oncology, Las Vegas, NV · Ian M. Thompson, University of Texas at San Antonio, San Antonio · John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX · Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia · Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada · Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom · Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD · Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ · David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles · Eric J. Small, University of California San Francisco, San Francisco, CA · Celestia S. Higano, University of Washington, Seattle, WA · and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY. · Pubmed 26951312
  • Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Laboratory for Advanced Genome Analysis (LAGA), Vancouver Prostate Centre, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Vancouver Prostate Centre, University of British Columbia, 2660 Oak St., Vancouver, BC, V6H 3Z6, Canada. · Pubmed 26813233
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Department of Life, Health, and Chemical Sciences, The Open University, Milton Keynes, UK. · Molecular Pathology Unit, Institute of Pathology University Hospital Basel, Switzerland. · Oncology, FHMS, School of Biosciences and Medicine, University of Surrey, UK. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Karolinska Institutet, Institute of Environmental Medicine, Unit of Biostatistics, Stockholm, Sweden. · Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Genetics Unit, Integrative Oncology, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · Cancer Center ZeTuP AG St.Gallen, St.Gallen, Switzerland. · Integrated DNA Technologies, Coralville, IA, USA. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. · The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada; Medical Oncology, BC Cancer Agency Vancouver Cancer Centre, Vancouver BC, Canada. · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada; The Vancouver Prostate Centre & Department of Urologic Sciences, University of British Columbia, Vancouver BC, Canada. Electronic address: · Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. Electronic address: · Pubmed 26809501
  • Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Institute of Biosciences and Medical Technology, Tampere, Finland. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 26797585
2015
  • Department of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada. · The Vancouver Prostate Centre, 2775 Laurel Street, 6th Floor, Vancouver, BC V5Z 1M9, Canada. · Pubmed 25512207
  • BC Cancer Agency, Vancouver, BC, Canada. · Cross Cancer Institute, Edmonton, AB, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Janssen Research & Development, Beerse, Belgium. · Janssen Research & Development, San Diego, CA, USA. · Janssen Research & Development, Los Angeles, CA, USA. · Janssen Research & Development, Titusville, NJ, USA. · Pubmed 26096139
  • Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington · Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle · Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA · Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT · Sumanta K. Pal, City of Hope, Duarte · David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA · Ajjai Alva, University of Michigan, Ann Arbor · Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI · Elaine T. Lam, University of Colorado, Denver, CO · Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL · Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC · Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada · Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV · and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX. · Pubmed 25847934
  • Department of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, USA · Academic Unit of Clinical Oncology, Sheffield Cancer Research Centre, Sheffield, UK. · Division of Urology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Canada. · Department of Medical Oncology, The Queen Elizabeth Hospital, Woodville, Australia. · Department of Electroradiology, Poznan University of Medical Sciences, Poznan Department of Radiotherapy, Wielkopolskie Centrum Onkologii, Poznan, Poland. · St John of God Hospital, Subiaco, Australia. · Department of Medical Oncology, BC Cancer Agency, Vancouver, Canada. · Department of Hematology/Oncology. · Global Biostatistical Science, Amgen Inc., Thousand Oaks, USA. · Department of Medical Oncology, Institut Gustave Roussy, University of Paris Sud, Paris, France. · Pubmed 25425475
  • Princess Margaret Hospital, Phase II Consortium, Toronto, ON. · Department of Oncology, Queen's University, Kingston, ON. · BC Cancer Agency, Vancouver, BC. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD. · BC Cancer Agency, Vancouver, BC. Electronic address: · Pubmed 24993934
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California. · Department of Urology, UCSF, UCSF Diller Comprehensive Cancer Center, San Francisco, California. · Department of Pathology and Laboratory Medicine, OHSU Knight Cancer Institute, Portland, Oregon. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver, British Columbia, Canada. Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 25712683
  • 1] University of Washington, Seattle, WA, USA [2] Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · Fred Hutchinson Cancer Research Center, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Sidney Kimmel Cancer Center/Johns Hopkins University, Baltimore, MA, USA. · City of Hope Cancer Center, Duarte, CA, USA. · Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA. · Huntsman Cancer Institute/University of Utah, Salt Lake City, UT, USA. · Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Pubmed 25600186
  • Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Microbiology and Immunology, University of British Columbia, Vancouver, BC, Canada. · Department of Medicine, Division of Medical Oncology, BC Cancer Agency, University of British Columbia, Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 25428917
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 25018038
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 24508071
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address: · Pubmed 25864159
2014
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Department of Pathology and Laboratory Medicine and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address: · Pubmed 24787970
  • Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Department of Biology, Kwantlen Polytechnic University, Surrey, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada. · Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Mechanical Engineering, University of British Columbia, Vancouver, British Columbia, Canada ; Vancouver Prostate Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada ; Department of Urologic Science, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 24416373
  • Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: · Janssen Research & Development, Los Angeles, CA, USA. · Medical University of Vienna, Vienna, Austria. · University of Montreal, Montreal, QC, Canada. · University of Washington, Seattle, WA, USA. · British Columbia Cancer Agency, Vancouver, BC, Canada. · Janssen Research & Development, Raritan, NJ, USA. · Institut Gustave Roussy, University of Paris Sud, Villejuif, France. · Pubmed 24099659
2013
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
  • British Columbia Cancer Agency, Vancouver, BC, Canada. · Pubmed 23064959
2012
  • Vancouver Prostate Centre, Vancouver, British Columbia, Canada. · Pubmed 22553344
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Centre, Vancouver, BC, Canada. · Pubmed 21765178
2011
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 22329189
2010
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 20733135
2009
2017
  • Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Institute of Biosciences and Medical Technology, University of Tampere, Tampere, Finland; Department of Medicine and Department of Radiation Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA; Oregon Health and Science University (OHSU) Knight Cancer Institute, Portland, OR; Department of Urology, University of California, Davis, School of Medicine, Sacremento, CA; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 29206995
2015
2014
  • British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, BC, Canada. · Pubmed 24671507
  • Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 25175831
  • Experimental Therapeutics, BC Cancer Agency Cancer Research Centre, Vancouver BC, Canada. · Pubmed 24519926
  • Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada; Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada. · Pubmed 24443367
2013
  • BC Cancer Agency, Vancouver, British Columbia, Canada. · Pubmed 23660300
  • BC Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6. · Pubmed 23337761
  • Department of Medical Oncology, BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Pubmed 23585511
2012
  • BC Cancer Agency - Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 4E6. · Pubmed 21785998
2010
  • Division of Medical Oncology, BC Cancer Agency - Vancouver Cancer Centre, 600 West 10th Avenue, Vancouver, British Columbia V5Z 4E6, Canada. · Pubmed 20152524
  • Department of Medical Oncology, Vancouver Centre, British Columbia Cancer Agency, Vancouver, Canada. · Pubmed 19633045
Miscellaneous institutions in Vancouver
2016
  • British Columbia Cancer Agency, Vancouver, British Columbia, Canada. · Vancouver Prostate Center, Vancouver, British Columbia, Canada. · Pubmed 27345496
2012
  • Bristish Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, British Columbia, V5Z 4E6, Canada. · Pubmed 23130925
University of Washington
2013
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
Harvard University Boston
2013
  • From the BC Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada; Dana-Farber Cancer Institute, Boston, MA; Univeristy of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA. · Pubmed 23714494
2016
  • Howard I. Scher, Michael J. Morris, Dana E. Rathkopf, and Susan F. Slovin, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College · David Nanus, NewYork Presbyterian Weill Cornell Medical Center · Lawrence W. Schwartz, NewYork Presbyterian Columbia University Medical Center, New York, NY · Walter M. Stadler, University of Chicago Medicine, Chicago, IL · Celestina Higano and Peter S. Nelson, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA · Ethan Basch, University of North Carolina at Chapel Hill, Chapel Hill, NC · Emmanual S. Antonarakis and Michael A. Carducci, Johns Hopkins University School of Medicine, Baltimore, MD · Tomasz M. Beer, Oregon Health and Science University, Portland, OR · Paul G. Corn and Christopher Logothetis, MD Anderson Cancer Center, Houston, TX · Robert Dreicer, University of Virginia School of Medicine, Charlottesville, VA · Daniel J. George, Susan Halabi, and Andrew J. Armstrong, Duke University and Duke Cancer Institute, Durham, NC · Elisabeth I. Heath, Wayne State University Karmanos Cancer Institute, Detroit · and Maha Hussain, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI · Wm. Kevin Kelly, Sidney Kimmel School of Medicine at Thomas Jefferson University, Philadelphia, PA · Glenn Liu and George Wilding, University of Wisconsin Carbone Cancer Center, Madison, WI · Mark N. Stein, The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ · Charles S. Ryan and Eric J. Small, University of California Helen Diller Family Comprehensive Cancer Center, San Francisco, CA · Oliver Sartor, Tulane School of Medicine, New Orleans, LA · Matthew Raymond Smith, Massachusetts General Hospital Cancer Center and Harvard Medical School · Mary-Ellen Taplin and Philip W. Kantoff, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA · Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, Franc · Pubmed 26903579
37 Other Locations Show
Yearly article counts 261113159910531
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.